Effect of cytostatic agents on the number of alveolar phagocytes and the efficacy of ceftriaxone in an experimental murine lung infection.

Mice made monocytopenic and granulocytopenic by cyclophosphamide or monocytopenic by etoposide were infected by exposure to an aerosol containing Klebsiella pneumoniae. Eighteen hours later ceftriaxone was administered and three hours after that the experiment was ended. At the time of infection and at 18 and 21 h the numbers of alveolar macrophages and granulocytes in bronchoalveolar lavage (BAL) fluid were significantly lower in the cyclophosphamide-pretreated animals than in the controls. Furthermore, outgrowth of K. pneumoniae in the lungs was significantly stronger in cyclophosphamide-pretreated mice and a fourfold higher dose of ceftriaxone was needed to obtain the same antibacterial effect as in the controls. In the etoposide-pretreated mice the number of alveolar macrophages in BAL was not significantly lower than that in the controls, but the number of granulocytes was. Compared with the controls, there was no significant difference in the number of K. pneumoniae in the lungs, and the efficacy of ceftriaxone did not differ either.

[1]  T. Kamei,et al.  Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog. , 1989, The American review of respiratory disease.

[2]  R. van Furth,et al.  Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection , 1989, Antimicrobial Agents and Chemotherapy.

[3]  W. Craig,et al.  Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. , 1989, The Journal of infectious diseases.

[4]  I. Bakker-Woudenberg,et al.  Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats , 1987, Antimicrobial Agents and Chemotherapy.

[5]  R. van Furth,et al.  Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection , 1987, Antimicrobial Agents and Chemotherapy.

[6]  K. Nugent,et al.  Effect of Alkylating Agents on the Clearance of Staphylococcus aureus From Murine Lungs , 1987, Journal of Leukocyte Biology.

[7]  I. Bakker-Woudenberg,et al.  Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats , 1986, Antimicrobial Agents and Chemotherapy.

[8]  M. Dunn,et al.  The effects of hyperoxia on pulmonary clearance of Pseudomonas aeruginosa. , 1986, The Journal of infectious diseases.

[9]  A. Gerber,et al.  Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. , 1986, The Journal of infectious diseases.

[10]  R. van Furth,et al.  Method to select mice in the steady state for biological studies. , 1985, Journal of immunological methods.

[11]  J. Hermans,et al.  Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis , 1983, Infection and immunity.

[12]  G. Toews,et al.  Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus. , 1983, The American review of respiratory disease.

[13]  J. Rahal,et al.  Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections , 1982, Antimicrobial Agents and Chemotherapy.

[14]  G. Simon,et al.  Efficacy of ceftriaxone in serious bacterial infections , 1982, Antimicrobial Agents and Chemotherapy.

[15]  W. Johanson,et al.  Colonization and bronchopulmonary infection. , 1982, Clinics in chest medicine.

[16]  G. Toews,et al.  Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. , 1981, The American review of respiratory disease.

[17]  G. Warr,et al.  Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice. , 1981, The American review of respiratory disease.

[18]  R. Wise,et al.  Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin , 1980, Antimicrobial Agents and Chemotherapy.

[19]  S. Rehm,et al.  Early bacterial clearance from murine lungs. Species-dependent phagocyte response. , 1980, The Journal of clinical investigation.

[20]  G. Toews,et al.  The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. , 2015, The American review of respiratory disease.

[21]  R. Furth,et al.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. , 1979 .

[22]  R. van Furth,et al.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state , 1979, The Journal of experimental medicine.

[23]  J. Pennington,et al.  Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression. , 1978, The Journal of infectious diseases.

[24]  G. Bodey,et al.  Fever and infection in leukemic patients. A study of 494 consecutive patients , 1978, Cancer.

[25]  R. Reynolds,et al.  Leukocytic response to inhaled bacteria. , 2015, The American review of respiratory disease.

[26]  L. Sandkuyl,et al.  Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. , 1977, Blood.

[27]  K. R. May.  The collison nebulizer: Description, performance and application , 1973 .

[28]  D. W. Henderson.  An apparatus for the study of airborne infection , 1952, Journal of Hygiene.